Document Detail


Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients.
MedLine Citation:
PMID:  21063874     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Adipocyte fatty acid binding protein (A-FABP) has been reported to be involved in insulin resistance, lipid metabolism, and atherosclerosis; however, little is known about the effect of medication on the change in circulating A-FABP in human subjects. We evaluated the effects of angiotensin II type 1 receptor blocker (ARB) on arterial stiffness and its association with serum A-FABP in patients with hypertension. Thirty patients newly diagnosed with essential hypertension were treated with olmesartan (20 mg/day), an ARB, for 6 months. Serum levels of A-FABP and high-sensitivity C-reactive protein (hsCRP) were examined and the cardio-ankle vascular index (CAVI), which is a marker of arterial stiffness, was also determined. Serum A-FABP at baseline was significantly correlated with the body mass index (r = 0.45, P = 0.01), homeostasis model assessment as a marker of insulin resistance (r = 0.53, P < 0.01), and systolic blood pressure (r = 0.37, P = 0.047), and tended to be correlated with low-density lipoprotein cholesterol, triglyceride, and CAVI. Olmesartan treatment resulted in a significant decrease in CAVI, serum A-FABP levels, and hsCRP, besides a significant reduction of blood pressure. Multiple regression analysis revealed that the change in CAVI was independently correlated with the change in serum A-FABP. Olmesartan ameliorated arterial stiffness in patients with hypertension, which may be involved in the reduction of serum A-FABP.
Authors:
Toru Miyoshi; Masayuki Doi; Satoshi Hirohata; Shigeshi Kamikawa; Shinichi Usui; Hiroko Ogawa; Kosuke Sakane; Reishi Izumi; Yoshifumi Ninomiya; Shozo Kusachi
Related Documents :
22886514 - Renal denervation therapies for refractory hypertension.
23454474 - A linear relationship between the ex-vivo sodium mediated expression of two sodium regu...
8541004 - Vitamin d is related to blood pressure and other cardiovascular risk factors in middle-...
17022874 - Cardiovascular disease prevention: the new joint british societies' guidelines.
24108864 - Blood pressure and cardiovascular mortality in dialysis patients with left ventricular ...
2908304 - Haemodynamic effects of new beta-blockers with vasodilatory properties in essential hyp...
Publication Detail:
Type:  Journal Article     Date:  2010-11-10
Journal Detail:
Title:  Heart and vessels     Volume:  26     ISSN:  1615-2573     ISO Abbreviation:  Heart Vessels     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-07-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8511258     Medline TA:  Heart Vessels     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  408-13     Citation Subset:  IM    
Affiliation:
Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan, miyoshit@cc.okayama-u.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A general model for the dynamics of cell volume, global stability, and optimal control.
Next Document:  Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fra...